{"id":58146,"date":"2024-11-18T19:28:39","date_gmt":"2024-11-18T19:28:39","guid":{"rendered":"https:\/\/cdhf.staging.not4prod.com\/?p=58146"},"modified":"2024-11-28T20:14:10","modified_gmt":"2024-11-28T20:14:10","slug":"disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici","status":"publish","type":"post","link":"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/","title":{"rendered":"Disponibilit\u00e9 de Remsima\u2122 SC pour les patients canadiens atteints de MICI"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Communiqu\u00e9 de presse :<\/strong> 20 novembre 2024<\/p>\n\n<p class=\"wp-block-paragraph\">La Fondation canadienne pour la promotion de la sant\u00e9 digestive s&#8217;engage \u00e0 soutenir les personnes atteintes de MII et \u00e0 les sensibiliser aux progr\u00e8s susceptibles d&#8217;am\u00e9liorer les soins aux patients. Le Canada a l&#8217;un des taux les plus \u00e9lev\u00e9s de maladies inflammatoires de l&#8217;intestin (MII) au monde, affectant les personnes atteintes de la maladie de Crohn (MC) et de la colite ulc\u00e9reuse (CU). La prise en charge des cas mod\u00e9r\u00e9s \u00e0 s\u00e9v\u00e8res de MICI pr\u00e9sente souvent des d\u00e9fis importants pour les patients, les soignants et le syst\u00e8me de sant\u00e9.<\/p>\n\n<p class=\"wp-block-paragraph\">Une formulation sous-cutan\u00e9e de l&#8217;infliximab est d\u00e9sormais disponible au Canada pour les personnes atteintes de MICI mod\u00e9r\u00e9es \u00e0 s\u00e9v\u00e8res &#8211; Remsima\u2122 SC (infliximab injectable). Cette formulation permet l&#8217;auto-administration du m\u00e9dicament directement dans le tissu sous la peau. Les personnes atteintes de MII devraient consulter leurs fournisseurs de soins de sant\u00e9 pour d\u00e9terminer si cette option de traitement peut convenir \u00e0 leurs besoins particuliers.  <\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Approbation de Remsima\u2122 SC par Sant\u00e9 Canada &#8211; Communiqu\u00e9 de presse :<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20240217328992\/en\/Health-Canada-Approves-Remsima%E2%84%A2-SC-for-the-Treatment-of-Inflammatory-Bowel-Disease-IBD\">https:\/\/www.businesswire.com\/news\/home\/20240217328992\/en\/Health-Canada-Approves-Remsima%E2%84%A2-SC-for-the-Treatment-of-Inflammatory-Bowel-Disease-IBD<\/a><\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Pour plus d&#8217;informations sur Celltrion, visitez le site web de la soci\u00e9t\u00e9 pharmaceutique :<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">Celltrion Healthcare Canada <a href=\"https:\/\/www.celltrionhealthcare.ca\/products\/product\/?pkey=59\">https:\/\/www.celltrionhealthcare.ca\/products\/product\/?pkey=59<\/a><\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Pour plus d&#8217;informations sur Celltrion Connect, le programme de soutien aux patients de Celltrion Healthcare, visitez le site web de la soci\u00e9t\u00e9 pharmaceutique :<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">Celltrion Healthcare Canada<\/p>\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.celltrionhealthcare.ca\/contactus\/connect\">https:\/\/www.celltrionhealthcare.ca\/contactus\/connect<\/a><\/p>\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/celltrionconnect.ca\">https:\/\/celltrionconnect.ca<\/a><\/p>\n\n<p class=\"wp-block-paragraph\">Pour plus d&#8217;informations sur les MII et les traitements disponibles, consultez un professionnel de la sant\u00e9 ou acc\u00e9dez \u00e0 des ressources \u00e9ducatives par l&#8217;interm\u00e9diaire d&#8217;organismes de sant\u00e9 de confiance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Communiqu\u00e9 de presse : 20 novembre 2024 La Fondation canadienne pour la promotion de la sant\u00e9 digestive s&#8217;engage \u00e0 soutenir les personnes atteintes de MII et \u00e0 les sensibiliser aux progr\u00e8s susceptibles d&#8217;am\u00e9liorer les soins aux patients. Le Canada a l&#8217;un des taux les plus \u00e9lev\u00e9s de maladies inflammatoires de l&#8217;intestin (MII) au monde, affectant [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":58197,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"cdhf2022_sponsors_meta":[],"footnotes":""},"categories":[111,168],"tags":[141],"class_list":["post-58146","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-article-fr","category-news-fr","tag-maladie-du-colon-irritable"],"acf":{"article_writer":[3779]},"featured_image_src":"https:\/\/cdhf.ca\/wp-content\/uploads\/2024\/11\/Banners-for-Website-Size-2024-11-18T141610.775.webp","author_info":{"display_name":"Kelsey Cheyne","author_link":"https:\/\/cdhf.ca\/fr\/author\/kelsey-cheyne\/"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Disponibilit\u00e9 de Remsima\u2122 SC pour les patients canadiens atteints de MICI - Canadian Digestive Health Foundation<\/title>\n<meta name=\"description\" content=\"Remsima\u2122 SC pour les patients atteints de MICI est un nouveau moyen plus flexible de recevoir un traitement, d\u00e9livrant de l&#039;infliximab par injection sous-cutan\u00e9e.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Disponibilit\u00e9 de Remsima\u2122 SC pour les patients canadiens atteints de MICI - Canadian Digestive Health Foundation\" \/>\n<meta property=\"og:description\" content=\"Remsima\u2122 SC pour les patients atteints de MICI est un nouveau moyen plus flexible de recevoir un traitement, d\u00e9livrant de l&#039;infliximab par injection sous-cutan\u00e9e.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Digestive Health Foundation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CDHFdn\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-18T19:28:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-28T20:14:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cdhf.ca\/wp-content\/uploads\/2024\/11\/Banners-for-Website-Size-2024-11-18T141610.775.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"3000\" \/>\n\t<meta property=\"og:image:height\" content=\"1350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Kelsey Cheyne\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TheCDHF\" \/>\n<meta name=\"twitter:site\" content=\"@TheCDHF\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kelsey Cheyne\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/\"},\"author\":{\"name\":\"Kelsey Cheyne\",\"@id\":\"https:\/\/cdhf.ca\/fr\/#\/schema\/person\/990293ff50f898caf38644b75a0105aa\"},\"headline\":\"Disponibilit\u00e9 de Remsima\u2122 SC pour les patients canadiens atteints de MICI\",\"datePublished\":\"2024-11-18T19:28:39+00:00\",\"dateModified\":\"2024-11-28T20:14:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/\"},\"wordCount\":304,\"publisher\":{\"@id\":\"https:\/\/cdhf.ca\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cdhf.ca\/wp-content\/uploads\/2024\/11\/Banners-for-Website-Size-2024-11-18T141610.775.webp\",\"keywords\":[\"Maladie du c\u00f4lon irritable\"],\"articleSection\":[\"Article\",\"News\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/\",\"url\":\"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/\",\"name\":\"Disponibilit\u00e9 de Remsima\u2122 SC pour les patients canadiens atteints de MICI - Canadian Digestive Health Foundation\",\"isPartOf\":{\"@id\":\"https:\/\/cdhf.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cdhf.ca\/wp-content\/uploads\/2024\/11\/Banners-for-Website-Size-2024-11-18T141610.775.webp\",\"datePublished\":\"2024-11-18T19:28:39+00:00\",\"dateModified\":\"2024-11-28T20:14:10+00:00\",\"description\":\"Remsima\u2122 SC pour les patients atteints de MICI est un nouveau moyen plus flexible de recevoir un traitement, d\u00e9livrant de l'infliximab par injection sous-cutan\u00e9e.\",\"breadcrumb\":{\"@id\":\"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/#primaryimage\",\"url\":\"https:\/\/cdhf.ca\/wp-content\/uploads\/2024\/11\/Banners-for-Website-Size-2024-11-18T141610.775.webp\",\"contentUrl\":\"https:\/\/cdhf.ca\/wp-content\/uploads\/2024\/11\/Banners-for-Website-Size-2024-11-18T141610.775.webp\",\"width\":3000,\"height\":1350,\"caption\":\"Remsima\u2122 SC injector at home\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cdhf.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Disponibilit\u00e9 de Remsima\u2122 SC pour les patients canadiens atteints de MICI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cdhf.ca\/fr\/#website\",\"url\":\"https:\/\/cdhf.ca\/fr\/\",\"name\":\"Canadian Digestive Health Foundation\",\"description\":\"Serving Canadians with the latest digestive health news &amp; information\",\"publisher\":{\"@id\":\"https:\/\/cdhf.ca\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cdhf.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cdhf.ca\/fr\/#organization\",\"name\":\"Canadian Digestive Health Foundation\",\"url\":\"https:\/\/cdhf.ca\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/cdhf.ca\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cdhf.ca\/wp-content\/uploads\/2022\/07\/CDHF_logo_sqstck_4line_CMYK.png\",\"contentUrl\":\"https:\/\/cdhf.ca\/wp-content\/uploads\/2022\/07\/CDHF_logo_sqstck_4line_CMYK.png\",\"width\":1154,\"height\":554,\"caption\":\"Canadian Digestive Health Foundation\"},\"image\":{\"@id\":\"https:\/\/cdhf.ca\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/CDHFdn\",\"https:\/\/x.com\/TheCDHF\",\"https:\/\/www.instagram.com\/cdhf_\/?hl=en\",\"https:\/\/www.youtube.com\/user\/CDHFtube\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cdhf.ca\/fr\/#\/schema\/person\/990293ff50f898caf38644b75a0105aa\",\"name\":\"Kelsey Cheyne\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Disponibilit\u00e9 de Remsima\u2122 SC pour les patients canadiens atteints de MICI - Canadian Digestive Health Foundation","description":"Remsima\u2122 SC pour les patients atteints de MICI est un nouveau moyen plus flexible de recevoir un traitement, d\u00e9livrant de l'infliximab par injection sous-cutan\u00e9e.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/","og_locale":"fr_FR","og_type":"article","og_title":"Disponibilit\u00e9 de Remsima\u2122 SC pour les patients canadiens atteints de MICI - Canadian Digestive Health Foundation","og_description":"Remsima\u2122 SC pour les patients atteints de MICI est un nouveau moyen plus flexible de recevoir un traitement, d\u00e9livrant de l'infliximab par injection sous-cutan\u00e9e.","og_url":"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/","og_site_name":"Canadian Digestive Health Foundation","article_publisher":"https:\/\/www.facebook.com\/CDHFdn","article_published_time":"2024-11-18T19:28:39+00:00","article_modified_time":"2024-11-28T20:14:10+00:00","og_image":[{"width":3000,"height":1350,"url":"https:\/\/cdhf.ca\/wp-content\/uploads\/2024\/11\/Banners-for-Website-Size-2024-11-18T141610.775.webp","type":"image\/png"}],"author":"Kelsey Cheyne","twitter_card":"summary_large_image","twitter_creator":"@TheCDHF","twitter_site":"@TheCDHF","twitter_misc":{"Written by":"Kelsey Cheyne","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/#article","isPartOf":{"@id":"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/"},"author":{"name":"Kelsey Cheyne","@id":"https:\/\/cdhf.ca\/fr\/#\/schema\/person\/990293ff50f898caf38644b75a0105aa"},"headline":"Disponibilit\u00e9 de Remsima\u2122 SC pour les patients canadiens atteints de MICI","datePublished":"2024-11-18T19:28:39+00:00","dateModified":"2024-11-28T20:14:10+00:00","mainEntityOfPage":{"@id":"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/"},"wordCount":304,"publisher":{"@id":"https:\/\/cdhf.ca\/fr\/#organization"},"image":{"@id":"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/#primaryimage"},"thumbnailUrl":"https:\/\/cdhf.ca\/wp-content\/uploads\/2024\/11\/Banners-for-Website-Size-2024-11-18T141610.775.webp","keywords":["Maladie du c\u00f4lon irritable"],"articleSection":["Article","News"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/","url":"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/","name":"Disponibilit\u00e9 de Remsima\u2122 SC pour les patients canadiens atteints de MICI - Canadian Digestive Health Foundation","isPartOf":{"@id":"https:\/\/cdhf.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/#primaryimage"},"image":{"@id":"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/#primaryimage"},"thumbnailUrl":"https:\/\/cdhf.ca\/wp-content\/uploads\/2024\/11\/Banners-for-Website-Size-2024-11-18T141610.775.webp","datePublished":"2024-11-18T19:28:39+00:00","dateModified":"2024-11-28T20:14:10+00:00","description":"Remsima\u2122 SC pour les patients atteints de MICI est un nouveau moyen plus flexible de recevoir un traitement, d\u00e9livrant de l'infliximab par injection sous-cutan\u00e9e.","breadcrumb":{"@id":"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/#primaryimage","url":"https:\/\/cdhf.ca\/wp-content\/uploads\/2024\/11\/Banners-for-Website-Size-2024-11-18T141610.775.webp","contentUrl":"https:\/\/cdhf.ca\/wp-content\/uploads\/2024\/11\/Banners-for-Website-Size-2024-11-18T141610.775.webp","width":3000,"height":1350,"caption":"Remsima\u2122 SC injector at home"},{"@type":"BreadcrumbList","@id":"https:\/\/cdhf.ca\/fr\/disponibilite-de-remsima-sc-pour-les-patients-canadiens-atteints-de-mici\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cdhf.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Disponibilit\u00e9 de Remsima\u2122 SC pour les patients canadiens atteints de MICI"}]},{"@type":"WebSite","@id":"https:\/\/cdhf.ca\/fr\/#website","url":"https:\/\/cdhf.ca\/fr\/","name":"Canadian Digestive Health Foundation","description":"Serving Canadians with the latest digestive health news &amp; information","publisher":{"@id":"https:\/\/cdhf.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cdhf.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/cdhf.ca\/fr\/#organization","name":"Canadian Digestive Health Foundation","url":"https:\/\/cdhf.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/cdhf.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/cdhf.ca\/wp-content\/uploads\/2022\/07\/CDHF_logo_sqstck_4line_CMYK.png","contentUrl":"https:\/\/cdhf.ca\/wp-content\/uploads\/2022\/07\/CDHF_logo_sqstck_4line_CMYK.png","width":1154,"height":554,"caption":"Canadian Digestive Health Foundation"},"image":{"@id":"https:\/\/cdhf.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CDHFdn","https:\/\/x.com\/TheCDHF","https:\/\/www.instagram.com\/cdhf_\/?hl=en","https:\/\/www.youtube.com\/user\/CDHFtube"]},{"@type":"Person","@id":"https:\/\/cdhf.ca\/fr\/#\/schema\/person\/990293ff50f898caf38644b75a0105aa","name":"Kelsey Cheyne"}]}},"_links":{"self":[{"href":"https:\/\/cdhf.ca\/fr\/wp-json\/wp\/v2\/posts\/58146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdhf.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdhf.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdhf.ca\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cdhf.ca\/fr\/wp-json\/wp\/v2\/comments?post=58146"}],"version-history":[{"count":0,"href":"https:\/\/cdhf.ca\/fr\/wp-json\/wp\/v2\/posts\/58146\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/cdhf.ca\/fr\/wp-json\/wp\/v2\/cdhf-writers\/3779"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdhf.ca\/fr\/wp-json\/wp\/v2\/media\/58197"}],"wp:attachment":[{"href":"https:\/\/cdhf.ca\/fr\/wp-json\/wp\/v2\/media?parent=58146"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdhf.ca\/fr\/wp-json\/wp\/v2\/categories?post=58146"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdhf.ca\/fr\/wp-json\/wp\/v2\/tags?post=58146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}